Page 1 | Search Results | Blood Advances | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Impact of a grant program to spur advances in sickle cell disease research

Sindy N. Escobar Alvarez, Elizabeth R. Myers

Blood Adv (2021) 5 (19): 3855–3861.

https://doi.org/10.1182/bloodadvances.2021005709

Published: 2021

Includes: Supplemental data

Journal Articles

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, Fouza I. Yusuf, Julie A. Panepinto

Blood Adv (2021) 5 (13): 2717–2724.

https://doi.org/10.1182/bloodadvances.2021004288

Published: 2021

Includes: Supplemental data

Journal Articles

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Alexis Leonard, Akshay Sharma, Naoya Uchida, David Stroncek, Sandhya R. Panch, Kamille West, Eoghan Molloy, Thomas E. Hughes, Sara Hauffe, Tiffani Taylor, Courtney Fitzhugh, Jane S. Hankins, Megan Wilson, Shengdar Q. Tsai, Mitchell J. Weiss, Matthew Hsieh, John F. Tisdale

Blood Adv (2021) 5 (9): 2403–2411.

https://doi.org/10.1182/bloodadvances.2021004232

Published: 2021

Includes: Supplemental data

Journal Articles

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Mark T. Vander Lugt, Xiaohua Chen, Maria L. Escolar, Beth A. Carella, Jessie L. Barnum, Randy M. Windreich, Memphis J. Hill, Michelle Poe, Rebecca A. Marsh, Heather Stanczak, Elizabeth O. Stenger, Paul Szabolcs

Blood Adv (2020) 4 (13): 3041–3052.

https://doi.org/10.1182/bloodadvances.2020001940

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

Andrew Srisuwananukorn, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk, Santosh L. Saraf

Blood Adv (2020) 4 (9): 1978–1986.

https://doi.org/10.1182/bloodadvances.2019001384

Published: 2020

Includes: Supplemental data

Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults

M. R. DeBaun, L. C. Jordan, A. A. King, J. Schatz, E. Vichinsky, C. K. Fox, R. C. McKinstry, P. Telfer, M. A. Kraut, L. Daraz, F. J. Kirkham, M. H. Murad

Blood Adv (2020) 4 (8): 1554–1588.

https://doi.org/10.1182/bloodadvances.2019001142

Published: 2020

Includes: Supplemental data

Journal Articles

American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease

Robert I. Liem, Sophie Lanzkron, Thomas D. Coates, Laura DeCastro, Ankit A. Desai, Kenneth I. Ataga, Robyn T. Cohen, Johnson Haynes, Jr, Ifeyinwa Osunkwo, Jeffrey D. Lebensburger, James P. Lash, Theodore Wun, Madeleine Verhovsek, Elodie Ontala, Rae Blaylark, Fares Alahdab, Abdulrahman Katabi, Reem A. Mustafa

Blood Adv (2019) 3 (23): 3867–3897.

https://doi.org/10.1182/bloodadvances.2019000916

Published: 2019

Includes: Supplemental data

Journal Articles

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial

Luisanna M. Sánchez, Rosa M. Nieves, Teresa Latham, Susan Stuber, Judy R. Luden, Gabriela S. Urcuyo, Melissa E. Berges, Carla Florencio, Carla Gonzalez, Paola del Villar, Adam Lane, William Schultz, Neelum Jeste, Rafael Mena, Russell E. Ware

Blood Adv (2018) 2 (Supplement_1): 50–53.

https://doi.org/10.1182/bloodadvances.2018GS110818

Published: 2018

Journal Articles

Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi

Tisungane Mvalo, Hillary Topazian, Portia Kamthunzi, Jane Chen, Isobel Kambalame, Pilirani Mafunga, Noel Mumba, Msandeni Chiume-Chiphaliwali, Khadija Paseli, Nigel Key, Satish Gopal, Irving Hoffman, Ken Ataga, Kate Westmoreland

Blood Adv (2018) 2 (Supplement_1): 30–32.

https://doi.org/10.1182/bloodadvances.2018GS110347

Published: 2018

Journal Articles

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera

Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, Xiaomei Ma

Blood Adv (2018) 2 (20): 2681–2690.

https://doi.org/10.1182/bloodadvances.2018021436

Published: 2018

Includes: Supplemental data

Journal Articles

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

Ahmed A. Daak, Carlton D. Dampier, Beng Fuh, Julie Kanter, Ofelia A. Alvarez, L. Vandy Black, Melissa A. McNaull, Michael U. Callaghan, Alex George, Lynne Neumayr, Lee M. Hilliard, Fredrick Sancilio, Adrian L. Rabinowicz, Matthew M. Heeney

Blood Adv (2018) 2 (15): 1969–1979.

https://doi.org/10.1182/bloodadvances.2018021444

Published: 2018

Includes: Supplemental data

Journal Articles

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia

Lili Aslostovar, Allison L. Boyd, Mohammed Almakadi, Tony J. Collins, Darryl P. Leong, Rommel G. Tirona, Richard B. Kim, Jim A. Julian, Anargyros Xenocostas, Brian Leber, Mark N. Levine, Ronan Foley, Mickie Bhatia

Blood Adv (2018) 2 (15): 1935–1945.

https://doi.org/10.1182/bloodadvances.2018015677

Published: 2018

Includes: Supplemental data

Journal Articles

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

Sarah E. Fordham, Helen J. Blair, Claire J. Elstob, Ruth Plummer, Yvette Drew, Nicola J. Curtin, Olaf Heidenreich, Deepali Pal, David Jamieson, Catherine Park, John Pollard, Scott Fields, Paul Milne, Graham H. Jackson, Helen J. Marr, Tobias Menne, Gail L. Jones, James M. Allan

Blood Adv (2018) 2 (10): 1157–1169.

https://doi.org/10.1182/bloodadvances.2017015214

Published: 2018

Includes: Supplemental data

Journal Articles

Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea

Françoise Bernaudin, Cécile Arnaud, Annie Kamdem, Isabelle Hau, Françoise Lelong, Ralph Epaud, Corinne Pondarré, Serge Pissard

Blood Adv (2018) 2 (6): 626–637.

https://doi.org/10.1182/bloodadvances.2017014555

Published: 2018

Journal Articles

Disease severity and slower psychomotor speed in adults with sickle cell disease

Dana R. Jorgensen, Andrea Metti, Meryl A. Butters, Joseph M. Mettenburg, Caterina Rosano, Enrico M. Novelli

Blood Adv (2017) 1 (21): 1790–1795.

https://doi.org/10.1182/bloodadvances.2017008219

Published: 2017

Includes: Supplemental data

Journal Articles

Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Joep W. R. Sins, David J. Mager, Shyrin C. A. T. Davis, Bart J. Biemond, Karin Fijnvandraat

Blood Adv (2017) 1 (19): 1598–1616.

https://doi.org/10.1182/bloodadvances.2017007211

Published: 2017

Includes: Supplemental data

Journal Articles

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

Santosh L. Saraf, Titilola S. Akingbola, Binal N. Shah, Chinedu A. Ezekekwu, Omowunmi Sonubi, Xu Zhang, Lewis L. Hsu, Mark T. Gladwin, Roberto F. Machado, Richard S. Cooper, Victor R. Gordeuk, Bamidele O. Tayo

Blood Adv (2017) 1 (11): 693–698.

https://doi.org/10.1182/bloodadvances.2017005231

Published: 2017

NARROW

Impact of a grant program to spur advances in sickle cell disease research

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults

American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial

Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea

Disease severity and slower psychomotor speed in adults with sickle cell disease

Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only